The shifting digital health investment landscape in 2022
Signs point toward another historic year in VC investment, experts say, which will benefit the medical system as it evolves to encapsulate more digital services.
Signs point toward another historic year in VC investment, experts say, which will benefit the medical system as it evolves to encapsulate more digital services.
With other COVID-19 treatments ineffective against the variant or in short supply, the FDA is expanding its approval of Veklury to include outpatient use.
An overload of bureaucratic tasks, such as charting and paperwork, was doctors’ No. 1 reason for burnout, affecting 60% of those polled by Medscape.
The lawsuit claims nixing the mandate the Trump administration put in place is a “bait and switch.”
Resuming the process of determining whether people are still eligible for Medicaid may sound easy, but stakeholders caution it’s much more nuanced than flipping a switch, and poor planning risks massive enrollment losses.
Despite the computing giant’s big aspirations for the potential of AI applications in medical research and clinical decisionmaking, Watson Health fell short and is now being sold for an undisclosed amount.
The sectors face continued operational pressure as they head into a third year of the pandemic, including a tight labor market and shifts in payer mix.
The government can’t require anyone to adopt TEFCA, raising concerns it won’t see enough voluntary uptake to create the coast-to-coast interoperability network envisaged by ONC. But competitive advantages to participation could get the ball rolling.
Support for rapid updates, the limitations of current reimbursement policies, cybersecurity risks as well as a “pressing need” for new regulatory frameworks are among the challenges facing DTx companies, according to researchers.
Black patients were 2.5 times more likely to have one or more negative descriptor such as “noncompliant” or “aggressive” in their EHR compared with White patients, researchers found.